Offer - Urjas Oil for just ₹ 1 X
Bortenat 3.5 Injection is a prescription medicine that is available as a Injection. Multiple Myeloma are some of its major therapeutic uses. Other than this, Bortenat 3.5 Injection has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Bortenat 3.5 Injection depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Bortenat 3.5 Injection can also lead to other problems, which have been listed below. Such side effects of Bortenat 3.5 Injection normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Bortenat 3.5 Injection's effect is Severe during pregnancy and Severe for lactating mothers. In addition, Bortenat 3.5 Injection's effects on the liver, heart and kidney are discussed below in the Bortenat 3.5 Injection related warnings section.
Individuals suffering from medical conditions like Gastrointestinal Bleeding must refrain from the use of Bortenat 3.5 Injection since this can cause severe adverse effects. The section on Bortenat 3.5 Injection contraindications lists all such conditions.
Drug interactions for Bortenat 3.5 Injection have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Bortenat 3.5 Injection is considered not safe while driving, and is not addictive.
Bortenat 3.5 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Bortenat 3.5 Injection safe for pregnant women?
Pregnant women may get severe side effects after taking Bortenat. If you are pregnant, do not take Bortenat without a doctor's advice.
Is the use of Bortenat 3.5 Injection safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Bortenat. It should only be taken after medical advice.
What is the effect of Bortenat 3.5 Injection on the Kidneys?
Bortenat is completely safe for kidneys.
What is the effect of Bortenat 3.5 Injection on the Liver?
You may experience side effects on your liver after taking Bortenat. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Bortenat 3.5 Injection on the Heart?
There may be an adverse effect on the heart after taking Bortenat. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
If you are suffering from any of the following diseases, you should not take Bortenat 3.5 Injection unless your doctor advises you to do so -
Is this Bortenat 3.5 Injection habit forming or addictive?
Bortenat 3.5 Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Bortenat 3.5 Injection as you may feel sleepy.
Is it safe?
Yes, but take Bortenat 3.5 Injection only as per medical advice.
Is it able to treat mental disorders?
No, Bortenat 3.5 Injection cannot treat any kind of mental disorder.
Interaction between Food and Bortenat 3.5 Injection
When consumed with certain foods, Bortenat 3.5 Injection may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Bortenat 3.5 Injection
Information about the interaction of Bortenat 3.5 Injection and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 234-235
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 871
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Velcade® (bortezomib)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Bortezomib Aft (Bortezomib)